CompanyDrug

BMS Announces Positive Outcomes for BMS-986278 in Progressive Pulmonary Fibrosis Study

CompanyDeals

Eurofarma Invests in Abcuro as Part of $100 Million Disruptive Startups and Biotech Initiative

CompanyDrug

EMA Reviews Janssen’s Balversa for Advanced Urothelial Carcinoma with FGFR3 Alterations

CompanyDrug

United Laboratories Receives Tacit Approval for JAK1 Inhibitor TUL01101 Clinical Trial

CompanyDrug

Jiangsu Hengrui Pharmaceuticals Gets NMPA Approval for Phase Ib/III Study of Dalpiciclib in mHSPC

CompanyDeals

Otsuka and Shape Therapeutics Partner on Ophthalmology Gene Therapies Development

CompanyDrug

Roche and Alnylam’s Zilebesiran Achieves Primary Endpoint in Hypertension Phase II Trial

Policy / Regulatory

CDE Annual Report: Clinical Trials for Innovative Drugs in China Reach Record High

CompanyDrug

Pfizer and Valneva’s Lyme Disease Vaccine VLA15 Shows Promise as Booster in Pediatric Trials

CompanyDrug

European Commission Approves Pediatric Indication for MSD’s Ervebo Ebola Vaccine

CompanyDrug

Cutia Therapeutics’ CU-40102 Meets Primary Endpoint in Phase III Study for Androgenic Alopecia

CompanyDrug

AstraZeneca’s Ultomiris Faces FDA Rejection for NMOSD Indication Extension